Suppression of apoptosis by survival factors is important for the maintenan
ce of normal tissue homoeostasis and the response to infection or injury. S
urvival factors such as insulin-like growth factor-I (IGF-I) initiate a sig
nalling cascade that starts by tyrosine phosphorylation of substrates leadi
ng to the activation of serine kinases that modulate the activity of member
s of the Bcl-2 family, which regulates the apoptotic machinery in most cell
s. Tumour cells often have enhanced survival mechanisms due either to up-re
gulation of the IGF-I receptor and its ligands or to loss of function of a
phosphatase (PTEN) that regulates part of this survival pathway. The C-term
inus of the IGF-I receptor appears to be a regulatory domain for the anti-a
poptotic activity of this receptor, and certain residues within the C-termi
nus are essential for this regulatory activity. Knowledge of the proteins a
nd pathways, which interact with these C-terminal domains, should lead us t
o ways of modulating IGF-I-mediated survival in tumours.